TrialJournal of diabetes investigation2019

Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal-bolus therapy).

Yuji Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.